Abstract:Graphical and Lay Summary L‐asparaginases (EC 3.5.1.1) catalyze the conversion of L‐asparagine to L‐aspartic acid and ammonia. Although bacterial L‐asparaginases are commonly used in leukemia treatment, their immunogenicity has necessitated the exploration of alternative sources. Yeast‐derived L‐asparaginases, such as Lachancea thermotolerans L‐asparaginase (LtASNase), present a potential strategy for reducing toxicity. In this study, the Lys99Ala mutant of LtASNase was generated through semi‐rational design, resulting in significantly enhanced activity. In vitro testing against leukemia cell lines demonstrated that the mutant enzyme exhibits antileukemic activity comparable to commercial bacterial enzymes. These findings highlight the potential of yeast‐derived L‐asparaginases for therapeutic development. L‐asparaginases (EC 3.5.1.1) are amidohydrolase enzymes that predominantly catalyze conversion of L‐asparagine to L‐aspartic acid and ammonia. In addition, some exhibit secondary L‐glutaminase activity. Escherichia coli and Erwinia chrysanthemi L‐asparaginases are widely used in the pharmaceutical industry to produce therapeutically important compounds. In the therapeutic use of enzymes, bacterial L‐asparaginases can trigger immune responses, leading to a high rate of adverse effects that diminish the effectiveness of the treatment. This situation has forced scientists to search for promising L‐asparaginases from new sources. Yeast L‐asparaginases could be useful in reducing toxicity and enhancing efficacy but they have been poorly studied to date. Here, we characterized the yeast Lachancea thermotolerans L‐asparaginase (LtASNase) purified by affinity chromatography. It has a specific activity of 313.8 U/mg and a high kcat value (312.4 s). We demonstrated through a semi‐rational design that the mutations of Lys99 show varying effects on catalytic activity, with the Lys99Ala mutant increasing specific activity 3.3‐fold. Furthermore, the in vitro antileukemic activity of the non‐formulated form of Lys99Ala LtASNase was evaluated against SUP‐B15 and REH cell lines. The results demonstrated that LtASNase exhibits significant antileukemic potential, comparable to commercial type II bacterial enzymes. The understanding of the mutant L‐asparaginases examined in this study will significantly contribute to the development of new and more effective yeast‐derived asparaginases.

Expression and purification of L-asparaginase from Escherichia coli and the inhibitory effects of cyclic dipeptides

Optimization of extracellular production of recombinant asparaginase in Escherichia coli in shake-flask and bioreactor

Production of highly cytotoxic and low immunogenic L-asparaginase from Stenotrophomonas maltophilia EMCC2297

Isolation of asparaginase-producing microorganisms and evaluation of the enzymatic antitumor activity

A Structural In Silico Analysis of the Immunogenicity of L-Asparaginase from Penicillium cerradense

Expression, characterization and cytotoxicity of recombinant l-asparaginase II from Salmonella paratyphi cloned in Escherichia coli

Heterologous Expression and Rational Design of l-asparaginase from Rhizomucor miehei to Improve Thermostability

Optimization of L-asparaginase production from endophytic Fusarium proliferatum using OFAT and RSM and its cytotoxic evaluation

Characterization of a Recombinant Glutaminase-Free l-Asparaginase (ansA3) Enzyme with High Catalytic Activity from Bacillus licheniformis

Characterization of a Novel Type I L-asparaginase from Acinetobacter Soli and Its Ability to Inhibit Acrylamide Formation in Potato Chips

Characterization of L-asparaginase from Streptomyces koyangensis SK4 with acrylamide-minimizing potential in potato chips

Production of Chemotherapeutic Enzyme L-asparaginase from a Fungal Source

A Comprehensive Review of L-Asparaginase: Production, Applications and Therapeutic Potential in Cancer Treatment

Biochemical characterization of glutaminase-free L-asparaginases from Himalayan Pseudomonas and Rahnella spp. for acrylamide mitigation

Microbial production, molecular modification, and practical application of l-Asparaginase: A review

Structures of L-Asparaginase from Bacillus Licheniformis Reveal an Essential Residue for Its Substrate Stereoselectivity.

A comprehensive review on microbial l-asparaginase: Bioprocessing, characterization, and industrial applications

Biotechnological production and practical application of L-asparaginase enzyme

Desirable L-asparaginases for treating cancer and current research trends

Enhancing L-Asparagine Bioproduction Efficiency Through L-Asparagine Synthetase and Polyphosphate Kinase-Coupled Conversion and ATP Regeneration

L‐Asparaginase from Lachancea Thermotolerans: Effect of Lys99Ala on Enzyme Performance and in vitro Antileukemic Efficacy